Shares of Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 4,010 shares changed hands during mid-day trading, an increase of 125% from the previous session’s volume of 1,781 shares.The stock last traded at $0.61 and had previously closed at $0.6439.
Sino Biopharmaceutical Price Performance
The company has a 50 day simple moving average of $0.63 and a 200-day simple moving average of $0.73.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Further Reading
- Five stocks we like better than Sino Biopharmaceutical
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
